Skip to content

Modifying Risk in Ventral Hernia Patients

Modifying Risk in Ventral Hernia Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02365194
Enrollment
284
Registered
2015-02-18
Start date
2015-05-31
Completion date
2019-07-31
Last updated
2018-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hernia, Ventral, Weight Loss

Keywords

Ventral Hernia, Prehabilitation

Brief summary

A pre-operative physical conditioning and weight loss intervention (prehabilitation) compared to standard counseling prior to ventral hernia repair for obese patients (BMI 30-40 kg/m2) at a safety-net hospital results in a higher proportion of patients being hernia- and complication-free 2 years after surgical consultation.

Detailed description

Background: Obesity is a risk factor for ventral hernia complications with or without repair, but the management strategy that best balances overall risks and benefits for obese patients with ventral hernias is unknown. The primary aim of this project is to compare the effect of prehabilitation (preoperative physical conditioning and weight loss intervention) versus standard preoperative counseling followed by repair for obese patients (BMI 30-40 kg/m2) with ventral hernias on outcomes. Methods: A comprehensive cohort study of obese patients who have ventral hernias will be performed. Within the comprehensive cohort study, patients who are candidates for elective ventral hernia repair will be randomized to a prehabilitation intervention or standard counseling with surgical repair once weight loss goals have been met. All patients will have repair after 6 months even if they have not met their weight loss goals. Patients who are not eligible for the trial or who refuse to participate will be followed in a non-randomized cohort; they will have their hernia repaired based upon current institution standards. (figure 1) The primary outcome of the study will be proportion of patients who are hernia- and complication- free 2 years after surgical consultation. This composite outcome was chosen in order to encompass all clinically important risks and benefits of both operative and non-operative strategies. Based on power calculations(alpha=0.05, beta=0.20), 232 eligible patients are needed assuming a 30% non-enrollment and 50% dropout. Since this is an efficacy trial, analysis will be performed per protocol as well as intention to treat. The primary outcome will be compared using the Cochran-Mantel-Haenszel test. Generalized linear mixed models (GLMMs) will be used to identify independent predictors of a successful outcome defined as hernia- and complication free at 2 years. In addition to a frequentist analysis, a Bayesian analysis will be performed. Posterior point estimates, credible intervals, and probability of increase in proportion of patients without hernias or complications will be calculated. Conclusion: Prehabilitation may have no impact on outcomes following ventral hernia repair, cause more complications with acute hernia presentation, or prove superior and decrease recurrences and complications compared to standard of care. This randomized controlled trial will provide baseline information on the efficacy of prehabiliation prior to open ventral hernia repair in obese patients.

Interventions

BEHAVIORALPrehabilitation

information included in arm description

information included in arm description

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient desires an elective surgical repair * Diagnosis of a ventral hernia with width on CT scan of 3-20 cm in diameter * Age 18 years or greater * Able to give informed consent * BMI of 30-40 kg/m2 * Surgical candidate based upon surgeon assessment

Exclusion criteria

* Patient has a severe comorbid condition likely to limit survival to \< 2 years * Patient has cirrhosis with or without ascites * Patient has a bowel obstruction, strangulation, peritonitis, or perforation * Patient has an indication for urgent surgery determined by surgeon such as full-thickness skin breakdown, enterocutaneous fistula, intermittent incarceration, or severe symptoms * Patient has a local or systemic infection * Patient is a prisoner * Patient is pregnant or intends to become pregnant during the study period

Design outcomes

Primary

MeasureTime frame
Proportion of patients who are hernia- and complication-free2 years after enrollment

Secondary

MeasureTime frameDescription
Receipt of elective or emergency surgery6 months after enrollmentWhen the patient underwent elective or emergent surgery
surgery-related complications (number of patients who developed infections or other complications related to the surgery)2 years after surgerynumber of patients who developed infections or other complications related to the surgery
hernia-related complications (number of patients who developed complications from their hernia)2 years after surgerynumber of patients who developed complications from their hernia
Weight loss (number of participants with weight loss of at least 7%)6 months after enrollmentnumber of participants with weight loss of at least 7%
implementation outcomes (difference in costs between the patients in the treatment group and those in the usual care group)2 yearsdifference in costs between the patients in the treatment group and those in the usual care group
Physiologic changes (number of pounds lost/gained)2 years after surgerynumber of pounds lost/gained
Metabolic changes (difference in basal metabolic rate before treatment and after treatment)2 years after surgerydifference in basal metabolic rate before treatment and after treatment
Functional Status (Quality of life questionnaire responses)2 years after surgeryQuality of life questionnaire responses

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026